Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-54175446 adjunctive antidepressant trial in major depressive disorder
ISRCTN44411633Phase 2Completed
- Sponsor
- Cambridgeshire and Peterborough NHS Foundation Trust
- Start
- Sep 2019
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of JNJ-54175446 in major depressive disorder (MDD), sponsored by Cambridgeshire and Peterborough NHS Foundation Trust. Primary endpoint: Primary efficacy endpoint. Started Sep 2019; status: completed.
02
Drugs
JNJ-54175446
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ISRCTN44411633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN44411633.